Flow cytometric study of blood leucocytes in clinical forms of human schistosomiasis

Scandinavian Journal of Immunology

Volumn 46, Issue 3, 1997, Pages 304-311

  Martins Filho, O A ^a,b   Dutra, W O ^a,b   Freeman, G L ^c   Silveira, A M S ^d   Rabello, A ^a   Colley, D G ^c   Prata, A ^e   Gazzinelli, G ^a   Correa Oliveira, R ^a   Carvalho Parra, J ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d UNIVERSIDADE VALE DO RIO DOCE   (Brazil)

^e FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; T LYMPHOCYTE;

EID: 9844258334     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-119.x     Document Type: Article

References (47)

1. Nash TE, Cheever AW, Ottesen EA, Cook JA. Schistosome infections in humanS: perspectives and recent findings. Ann Intern Med 1982;97:740-54.
2. Hiatt RA, Sotomayor ZR, Sanchez G, Zombrana M, Knight WB. Factors in the pathogenesis of acute schistosomiasis mansoni. J Infect Dis 1979;139:659-66.
3. Bogliolo L. Patologia. Rev Brasil Malariol e Doencças Trop 1959; Vol XI (2 e 3):359-424.
4. Prata A, Bina JC. Development of the hepatosplenic form of schistosomiasis: a study of 20 patients observed during a 5 year period. Gaz Med Bahia 1968;68:49-54.
5. Colley DG, Hieny SE, Bartholomew RK, Cook JA. Immune response during human schistosomiasis mansoni. III. Regulatory effect of patient sera on human lymphocytes blastogenic responses to schistosomal antigen preparations. Am J Trop Med Hyg 1977;26:917-25.
6. Colley DG, Lewis FA, Goodgame RW. Immune response during human schistosomiasis. IV. Induction of supressor cell activity by schistosome antigen preparations and concanavalin A. J Immunol 1978;120:1225-32.
7. Ottesen EA. Modulation of the host immune response in human schistosomiasis. I. Adherent suppressor cells that inhibit lymphocytes proliferative responses to parasite antigens. J Immunol 1979;123:1639-44.
8. Rocklin RE, Brown AP, Warren KS et al. Factors that modify the cellular-immune response in patients infected by S. mansoni. J Immunol 1980;125:1916-23.
9. Rocklin RE, Tracy JW, El Kholy A. Activation of antigen-specific supressor cells in human schistosomiasis mansoni by fraction soluble egg antigens nonadherent to Con A sepharose. J Immunol 1981;127:2314-18.
10. Doughty BL, Goes AM, Parra JC et al. Granulomatous hypersensitivity to S. mansoni egg antigens in human schistosomiasis. I. Granuloma formation and modulation around polyacrylamide antigen-conjugated beads. Mem Inst Oswaldo Cruz 1987;82:47-54.
11. Parra JC, Gazzinelli G, Goes AM et al. Granulomatous hypersensitivity to S. mansoni egg antigens in human schistosomiasis. II. In vitro granuloma modulation induced by polyclonal idiotypic antibodies. J Immunol 1991;147:3949-54.
12. Goes AM, Gazzinelli G, Rocha R, Katz N, Doughty BL. Granulomatous hypersensitivity to S. mansoni egg antigens in human schistosomiasis. III. In vitro granuloma modulation induced by immune complexes. Am J Trop Med Hyg 1991;44:434-43.
13. Todd CW, Goodgame RW, Colley DG. Immune responses during human schistosomiasis mansoni. V. Suppression of schistosome antigen-specific lymphocyte blastogenesis by adherent/phagocytic cells. J Immunol 1979;122:1440-6.
14. Todd CW, Goodgame RW, Colley DG. Immune responses during human schistosomiasis mansoni. VII. Further analysis of the interactions between patient sera and lymphocytes during in vitro blastogenesis to schistosome antigen preparations. Am J Trop Med Hyg 1980;29:875-81.
15. Nogueira-Machado JA, Silva EN, Katz N, Rocha RS, Gazzinelli G. Peripheral lymphocytes in patients with intestinal schistosomiasis mansoni. Trans Roy Soc Trop Med Hyg 1978;72:441
16. Colley DG, Katz N, Rocha RS, Abrantes W, Silva L, Gazzinelli G. Immune responses during human schistosomiasis mansoni. IX. T-lymphocyte subset analysis by monoclonal antibodies in hepatosplenic disease. Scand J Immunol 1983;17:297-302.
17. Gazzinelli G, Lambertucci JR, Katz N, Rocha RS, Lima MS, Colley DG. Immune response during human schistosomiasis mansoni. XI. Immunologic status of patients with acute infections and after treatment. J Immunol 1985;135:2121-7.
18. Katz N, Chaves A, Pellegrino J. A single device for quantitative stool thick-smear technique in schistosomiasis mansoni. Rev Inst Med Trop São Paulo 1972;14:397-400.
19. Weil GJ, Chused TM. Eosinophil autofluorescence and its use in isolation and analysis of human eosinophils using flow microfluorometry. Blood 1981;57:1099-104.
20. Lovett EJ, Schnitzer B, Keren DF, Flint A, Hudson JL, Mcclatchey KD. Application of flow cytometry to diagnostic pathology. Lab Invest 1984;50:115-40.
21. Caruso A, Cantalamessa A, Licenziati S et al. Expression of CD28 on CD8+ and CD4+ lymphocytes during HIV infection. Scand J Immunol 1994;40:485-90.
22. Dutra WO, Martins-Filho OA, Cançado JR et al. Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol 1994;6:499-506.
23. Dutra WO, Martins-Filho OA, Cançado JR et al. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand J Immunol 1996;43:88-93.
24. Damle NK, Mohagheghpour N, Engleman EG. Soluble antigen-primed inducer T cells activate antigen-specific supressor cells in the absence of antigen pulsed acessory cells: phenotype definition of suppressor-inducer and suppressor-effector cells. J Immunol 1984;131:644-50.
25. Takaya M, Ichikawa Y, Schimizu H, Uchiyama M, Moriuch J, Amori S. Expression of MHC Class II molecules and other T cell activation antigens on T cell and salivary duct epithelial cells in the salivary gland of cases of Sjögren'syndrome. Tokai J Exp Med 1990;15:27-33.
26. Vernino LA, Pisetsky DS, Lipsky PE. Analysis of the expression of CD5 by human B cells and correlation with functional activity. Cell Immunol 1992;139:185-97.
27. Jahn B, Burmester GR, Stock P, Rohwer P, Kalden JR. Functional and phenotypical characterization of activated T cells from intraarticular sits in inflammatory joint diseases: possible modulation of CD3 antigen. Scand J Immunol 1987;26:745-54.
28. Takacs L, Rusceti FW, Kovacs EJ et al. Immature, double negative CD4-CD8- rat thymocytes do not express IL-2 receptors. J Immunol 1988;141:3810-18.
29. Shirai T, Hirose S, Okada T, Nishimura H. CD5+ B cells in autoimune disease and lymphoid malignancy. Clin Immunol Immunopathol 1991;59:173-86.
30. Abe M, Tominaga K, Wakasa H. Phenotypic characterization of human B lymphocyte subpopulations, particularly CD5+ B-lymphocyte subpopulation within the mantle zone of secondary follicules. Leukemia 1994;8:1039-44.
31. Jarvis JN, Kaplan J, Fine N. Increase in CD5+ B cells in juvenile reumathoid arthrits. Relationship to IgM rheumatic factor expression and disease activity. Arthr Rheum 1992;35:204-7.
32. Domingo EO, Warren KS. The inhibition of granuloma formation around S. mansoni eggs. II. Thimectomy. Amer J Pathol 1967;51: 757-67.
33. Ellner JJ, Olds GR, Osman GS, El Kholy A, Mahoud AAF. Dichotomies in the reactivity to worm antigen in schistosomiasis. J Immunol 1981;16:309-12.
34. James SL, Sher A. Cell mediated response to schistosomiasis. Curr Trop Microbiol Immunol 1990;155:21-31.
35. Gerrard TL, Volkman DJ, Jurgensen CH, Fauci AS. Activated human T cells can present denatured antigen. Hum Immunol 1986;17:416-25.
36. Lanier LL, Le AM, Phillips JH, Warner NL, Babcook GF. Subpopulations of human natural killer cells defined by expression of Leu-7(HNK-1 and Leu-11(NK-15) antigens. J Immunol 1983;31:1789-96.
37. Perussia B, Fanning V, Trinchieri G. A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8. J Immunol 1983;131:223-31.
38. Chan SH, Perussia B, Gupta JW et al. Induction of interferon-gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991;173:869-79.
39. Zwingenberger K, Irschich E, Siqueira-Vergetti JG, Feldmeier H. Release of interleukin-2 and interferon-gamma by peripheral blood cells in human S. mansoni infection normalizes after chemotherapy. Scand J Immunol 1989;30:463-71.
40. Smith HR, Olson RR. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 1990;17:833-5.
41. Jasin HE. The relationship between circulating CD5+ B lymphocytes and in vitro autoantibody synthesis in normal individuals. Cell Immunol 1991;136:133-41.
42. Velupillai P, Secor WE, Herauf AM, Harn DA. B-I cell (CD5+B220+) outgrowth in mutine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol 1997;138:338-44.
43. Flores-Villanueva PO, Harris TS, Ricklan DE, Stadecker MJ. Macrophages from schistosomal egg induce unresponsiveness in specific cloned Th-1 lymphocytes in vitro and down-regulate schistosomal granulomatous disease in vivo. J Immunol 1994;152:1847-55.
44. Araujo MI, de Jesus AR, Bacelar O, Sabin E, Carvalho EM. Evidence of a T helper type 2 activation in human schistosomiasis. Eur J Immunol 1996;26:1399-403.
45. King CL, Medhat A, Malhotra I et al. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL10 modulates lymphocyte reactivity. J Immunol 1996;156:4715-21.
46. Galvão-Castro B, Bina JC, Prata A, Lambert PH. Correlation of circulating immune complexes and complement breakdown products with the severity of the disease in human schistosomiasis. Am J Trop Med Hyg 1981;30:1238-46.
47. Hoffman WQ, Pons JA, Janer JL. The sedimentation-concentration method in schistosomiasis mansoni. Puerto Rico J Publ Hlth Trop Med 1934;9:283-91.